Sunday, November 22, 2015

Ibogaine For The World -- Saturday 12/12, 5:30 pm -- Mill Valley California

Freedom Root Presents

Saturday December 12th
5:30 pm - 11:30 pm
Sweetwater Music Hall
19 Corte Madera Ave
Mill Valley CA 94941

Benefit reception, $52.
Panel discussion and Q&A, $22
Concert with Mark Karan and Friends, $32
Full VIP Package, $102
Tickets available at:
http://www.sweetwatermusichall.com/event/991907-ibogaine-for-world-benefit-mill-valley/

Speakers include:
Amy Emerson, MAPS
Christopher Laurance, Iboga Root Home
Dana Beal, Cures Not Wars
Eugene Schoenfeld, M.D., Dr. HIPpocrates

Update:
At the panel, we will also be discussing low-dose ibogaine treatment for Parkinson's disease. Speakers include "Patient D" who gets help from https://www.genesisibogainecenter.com/, and neuroscientist Dr. Vicka Corey, who will share on designing experimental research into this rainforest plant alkaloid.  See her C.V. at http://www.brainexplained.com/cv.html

Net proceeds to benefit international iboga/ine projects such as the 2016 Global Ibogaine Conference, Blessings of the Forest, and new addiction interruption efforts in Nepal and Afghanistan.

Public invited.  Doors at 5:00 p.m. for  the VIP reception (hors d'oeuvres with a cash bar).  Panel presentations and Q&A discussion 6:45 - 8:45.  Auction to benefit the IFW causes between panel and concert,  Celebration concert with Mark Karan and Friends begins at 9:30 p.m.

#FreedomRootPresents
#IFW
#IbogaineForTheWorld
#A.i.R.Fundraiser
#AddictionInterruption




DISCLAIMER:  At this time A.i.R. does not have the infrastructure to do direct aid to patients.   But because the regulatory situation in the U.S. (Schedule 1) makes it difficult for people in need to procure regular medical treatments except in places like Mexico and Costa Rica, A.i.R.'s mission will include a plan for supporting patients around these travels.  Please see the Ibogaine Alliance's new (September 2015) Clinical Guidelines for good information about the medical administration of iboga/ine at http://www.ibogainealliance.org/guidelines/

No comments:

Poll: Should the U.S. revisit the Schedule I status given to IBOGAINE in order to research its anti-addiction properties?